DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Kong S, Sengupta S, Tyler B. , et al.
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.
Clin Cancer Res 2012;
18 (21) 5949-5960
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.